CDT Equity (CDT) Research & Development (2022 - 2026)
CDT Equity's Research & Development came in at $302,000 for Q2 2026, down 83.8% from $1.86 million a year earlier and down 61.2% from the prior quarter.
Powered by 
Analysis
CDT Equity (CDT) Research & Development (2022 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, CDT Equity reported Research & Development of $3.36 million, down 44.0% year-over-year; for FY2025, it came in at $5.05 million, up 49.6% from FY2024.
- Research & Development carries a three-year compound annual growth rate of 415.0% (FY2022 to FY2025).
- Going back by year, Research & Development was $3.38 million in FY2024, $90,000 in FY2023 (+143.2%) and $37,000 in FY2022.
- The Q2 2026 figure represents the lowest quarterly Research & Development since Q4 2024.
- Year-over-year, Research & Development increased in two of the last five quarters, with growth averaging 186.3%.
- Business Quant data shows CDT's Research & Development at $778,000 (Q1 2026), $746,000 (Q4 2025) and $1.53 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 993.80 Mn |
| 10 | CDT Equity | 36,602.35 | 36,602.35 | - | 302,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 302,000.00 |
| Mar 31, 2026 | 778,000.00 |
| Dec 31, 2025 | 746,000.00 |
| Sep 30, 2025 | 1.53 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 916,000.00 |
| Dec 31, 2024 | 132,000.00 |
| Sep 30, 2024 | 3.09 Mn |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 128,000.00 |
| Dec 31, 2022 | -1,000.00 |
| Sep 30, 2022 | 38,000.00 |
API Access
CDT Equity Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CDT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CDT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CDT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();